IRIDEX CORP Royalty Expense
IRIDEX CORP (IRIX) reported Royalty Expense of $300.00 thousand for the 12-month period ending 2026-01-03, per its 10-K filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-04-02
- IRIDEX CORP royalty expense for fiscal 2026 was $300.00K, a 25.00% decline from fiscal 2024.
- IRIDEX CORP royalty expense for fiscal 2024 was $400.00K, a 0.00% change from fiscal 2023.
- IRIDEX CORP royalty expense for fiscal 2023 was $400.00K, a 0.00% change from fiscal 2022.
- IRIDEX CORP royalty expense for fiscal 2022 was $400.00K, a 0.00% change from fiscal 2022.
| Period end | Royalty Expense 12 month |
|---|---|
| 2026-01-03 | $300.00K 10-K · filed 2026-04-02 |
| 2024-12-28 | $400.00K 10-K · filed 2026-04-02 |
| 2023-12-30 | $400.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $400.00K 10-K · filed 2024-03-29 |
| 2022-01-01 | $400.00K 10-K · filed 2023-03-09 |
| 2021-01-02 | $300.00K 10-K · filed 2022-03-15 |
| 2019-12-28 | $400.00K 10-K · filed 2021-03-23 |
| 2018-12-29 | $300.00K 10-K · filed 2020-03-13 |
| 2017-12-30 | $300.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $300.00K 10-K · filed 2018-03-14 |
| 2016-01-02 | $100.00K 10-K · filed 2018-03-14 |
| 2015-01-03 | $200.00K 10-K · filed 2017-03-15 |
| 2013-12-28 | $100.00K 10-K · filed 2016-03-31 |
| 2012-12-29 | $100.00K 10-K · filed 2015-04-02 |
| 2011-12-31 | $200.00K 10-K · filed 2014-03-27 |
| 2011-01-01 | $100.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |